Skip to main content
Humedix Co., Ltd. logo

Humedix Co., Ltd. — Investor Relations & Filings

Ticker · 200670 ISIN · KR7200670008 KO Manufacturing
Open in API
Filings indexed 317 across all filing types
Latest filing 2020-03-11 Audit Report / Informat…
Country KR South Korea
Listing KO 200670

About Humedix Co., Ltd.

https://humedix.com/eng/home.php?go=Ame…

Humedix Co., Ltd. is a healthcare company that develops and manufactures biological and pharmaceutical products focused on human health and beauty. The company specializes in hyaluronic acid-based applications, producing medical devices such as dermal fillers and arthritis treatments. Its portfolio also includes prescription medicines, active pharmaceutical ingredients (APIs), and functional cosmetics. Additionally, Humedix offers Contract Manufacturing Organization (CMO) services within the healthcare sector.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a regulatory filing from Humedix titled 'Audit Report Submission' (감사보고서 제출). It provides a summary of the audit opinion (unqualified/proper), key financial data (assets, liabilities, equity, revenue, profit), and auditor information. While it contains financial data, it is a formal notification of the submission of the audit report to the regulatory body (DART), rather than the full annual report itself. According to the 'Menu vs Meal' rule, this is a report publication announcement regarding the audit results. FY 2019
2020-03-11 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a 'Reference Document' (참고서류) for a General Meeting of Shareholders, specifically for Humedix's 17th Annual General Meeting. It includes details on the proxy solicitation, voting rights, and the agenda items, including the approval of financial statements (balance sheets, income statements, etc.). This type of document is standard for proxy solicitation and shareholder information statements in the Korean market, which falls under the 'Proxy Solicitation & Information Statement' category.
2020-03-02 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the change in share ownership by a major shareholder (Huons Global) and related parties in the company Humedix. This type of filing is specifically used to notify the market when a shareholder crosses a significant ownership threshold or changes their holdings, which falls under the 'Major Shareholding Notification' category.
2020-02-27 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Humedix. It outlines the date, location, agenda items (such as financial statement approval, director appointments, and business purpose changes), and details regarding the board's resolution. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon.
2020-02-26 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Humedix. It contains the meeting agenda, details on voting procedures (including electronic voting), and management's report on business activities and financial statements. This type of document is specifically designed to provide shareholders with the necessary information to vote at the upcoming AGM, which falls under the Proxy Solicitation & Information Statement category.
2020-02-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership (including '장내매수' or on-market purchases), and the relationship between the reporting entity and the issuer (Humedix). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-02-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.